1. Polyomavirus BK;Hirsch,2003
2. 2. HHS/HRSA/HSB/DOT, UNOS, Arbor Research Collaborative for Health 2006 OPTN/SRTR Annual Report 1996-2005.
3. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation;Humar,2006
4. Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation - efficacy and safety at five years;Watson,2005
5. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody;Peleg,2007